Integrating and Mining Helminth Genomes to Discover and Prioritize Novel Therapeutic Targets

Parasitic Helminths: Targets, Screens, Drugs and Vaccines

Volumn , Issue , 2012, Pages 43-59

  Shanmugam, Dhanasekaran ^a   Ralph, Stuart A ^b   Carmona, Santiago J ^c   Crowther, Gregory J ^d   Roos, David S ^e   Agüero, Fernán ^c  

^a Division of Biochemical Sciences   (India)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c INSTITUTO DE INVESTIGACIONES BIOTECNOLÓGICAS   (Argentina)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Essentiality; Genome; Genomics; Helminth; Novel therapeutic; Orthology; RNA interference

Indexed keywords

EID: 84886197883     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527652969.ch3     Document Type: Chapter

References (51)

1. Holden-Dye, L. and Walker, R.J. (2007) Anthelmintic drugs, in WormBook (ed. The C. elegans Research Community), doi: 10.1895/wormbook.1.143.1.
2. Nwaka, S. and Hudson, A. (2006) Innovative lead discovery strategies for tropical diseases. Nat. Rev. Drug Discov., 5, 941-955.
3. Prichard, R.K. (1990) Anthelmintic resistance in nematodes: extent, recent understanding and future directions for control and research. Int. J. Parasitol., 20, 515-523.
4. Kaplan, R.M. (2004) Drug resistance in nematodes of veterinary importance: a status report. Trends Parasitol., 20, 477-481.
5. Osei-Atweneboana, M.Y., Eng, J.K.L., Boakye, D.A., Gyapong, J.O., and Prichard, R.K. (2007) Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet., 369, 2021-2029.
6. Osei-Atweneboana, M.Y., Awadzi, K., Attah, S.K., Boakye, D.A., Gyapong, J.O., and Prichard, R.K. (2011) Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus. PLoS Negl. Trop. Dis., 5, e998.
7. Berriman, M., Lustigman, S., and Mc Carter, J.P.(2007) Helminth initiative for drug discovery - report of the informal consultation, genomics and emerging drug discovery technologies. Expert Opin. Drug Discov., 2, S83-S89.
8. Brindley, P.J., Mitreva, M.,Ghedin, E., and Lustigman, S. (2009)Helminth genomics: the implications for human health. PLoS Negl. Trop. Dis., 3, e538.
9. Parkinson, J., Anthony, A., Wasmuth, J., Schmid, R., Hedley, A., and Blaxter, M. (2004) Partigene - constructing partial genomes. Bioinformatics, 20, 1398-1404.
10. Parkinson, J., Mitreva, M., Whitton, C., Thomson, M., Daub, J., Martin, J., Schmid, R., Hall, N. et al. (2004) A transcriptomic analysis of the phylum Nematoda. Nat. Genet., 36, 1259-1267.
11. Ramanathan, R., Varma, S., Ribeiro, J.M.C., Myers, T.G., Nolan, T.J., Abraham, D., Lok, J.B., and Nutman, T.B. (2011) Microarray-based analysis of differential gene expression between infective and noninfective larvae of Strongyloides stercoralis. PLoS Negl. Trop. Dis., 5, e1039.
12. Wasmuth, J., Schmid, R., Hedley, A., and Blaxter, M. (2008) On the extent and origins of genic novelty in the phylum Nematoda. PLoS Negl. Trop. Dis., 2, e258.
13. Marcilla, A., Sotillo, J., Pérez-Garcia, A., Igual-Adell, R., Valero, M.L., Sánchez-Pino, M.M., Bernal, D., Muñoz-Antolí.(2010) Proteomic analysis of Strongyloides stercoralis l3 larvae. Parasitology, 137, 1577-1583.
14. Mulvenna, J.,Hamilton, B., Nagaraj, S.H., Smyth, D., Loukas, A., and Gorman, J.J. (2009) Proteomics analysis of the excretory/secretory component of the blood-feeding stage of the hookworm, Ancylostoma caninum. Mol.Cell Proteomics, 8, 109-121.
15. Weinkopff, T., Atwood, J.A., Punkosdy, G.A., Moss, D., Weatherly, D.B., Orlando, R., and Lammie, P. (2009) Identification of antigenic Brugia adult worm proteins by peptide mass fingerprinting. J. Parasitol., 95, 1429-1435.
16. Stefanić, S., Dvoák, J., Horn, M., Braschi, S., Sojka, D., Ruelas, D.S., Suzuki, B., Lim, K. et al. (2010) RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening. PLoS Negl. Trop. Dis., 4, e850.
17. Benson, D.A., Karsch-Mizrachi, I., Lipman, D.J., Ostell, J., and Sayers, E.W. (2011) GenBank. Nucleic Acids Res., 39, D32-D37.
18. Hertz-Fowler, C., Peacock, C.S.,Wood, V., Aslett, M., Kerhornou, A., Mooney, P., Tivey, A., Berriman, M. et al. (2004) GeneDB: a resource for prokaryotic and eukaryotic organisms. Nucleic Acids Res., 32, D339-D343.
19. Aurrecoechea, C., Brestelli, J., Brunk, B.P., Fischer, S., Gajria, B., Gao, X., Gingle, A., Grant, G. et al. (2010) EuPathDB: a portal to eukaryotic pathogen databases. Nucleic Acids Res., 38, D415-D419.
20. Harris, T.W., Antoshechkin, I., Bieri, T., Blasiar, D., Chan, J., Chen, W.J., De La Cruz, N., Davis, P. et al. (2010) WormBase: a comprehensive resource for nematode research. Nucleic Acids Res., 38, D463-D467.
21. Kumar, S., Chaudhary, K., Foster, J.M., Novelli, J.F., Zhang, Y., Wang, S., Spiro, D., Ghedin, E. et al. (2007) Mining predicted essential genes of Brugia malayi for nematode drug targets. PLoS One, 2, e1189.
22. Caffrey, C.R., Rohwer, A., Oellien, F., Marhöer, R.J., Braschi, S., Oliveira, G., McKerrow, J.H., and Selzer, P.M. (2009) Acomparative chemogenomics strategy to predict potential drug targets in the metazoan pathogen, Schistosoma mansoni. PLoS One, 4, e4413.
23. Chen, F.,Mackey, A.J., Stoeckert, C.J., and Roos, D.S. (2006) OrthoMCL-DB: querying a comprehensive multi-species collection of ortholog groups.NucleicAcids Res., 34, D363-D368.
24. Agüro, F., Al-Lazikani, B., Aslett, M., Berriman, M., Buckner, F.S., Campbell, R.K., Carmona, S., Carruthers, I.M. et al. (2008) Genomicscale prioritization of drug targets: the TDR Targets database. Nat. Rev. Drug Discov., 7, 900-907.
25. C. elegans Sequencing Consortium (1998) Genome sequence of the nematode, C. elegans: a platform for investigating biology. Science, 282, 2012-2018.
26. Ghedin, E., Wang, S., Spiro, D., Caler, E., Zhao, Q., Crabtree, J., Allen, J.E., Delcher, A.L. et al. (2007) Draft genome of the filarial nematode parasite Brugia malayi. Science, 317, 1756-1760.
27. Berriman, M., Haas, B.J., LoVerde, P.T., Wilson, R.A., Dillon, G.P., Cerqueira, G.C., Mashiyama, S.T., Al-Lazikani, B. et al. (2009) The genome of the blood fluke Schistosoma mansoni. Nature, 460, 352-358.
28. Mitreva, M., Jasmer, D.P., Zarlenga, D.S., Wang, Z., Abubucker, S., Martin, J., Taylor, C.M., Yin, Y. et al. (2011) The draft genome of the parasitic nematode Trichinella spiralis. Nat. Genet., 43, 228-235.
29. Martin, J., Abubucker, S., Wylie, T., Yin, Y., Wang, Z., and Mitreva, M. (2009) Nematode.net update 2008: improvements enabling more efficient data mining and comparative nematode genomics. Nucleic Acids Res., 37, D571-D578.
30. Zerlotini, A., Heiges, M., Wang, H., Moraes, R.L.V., Dominitini, A.J., Ruiz, J.C., Kissinger, J.C., and Oliveira, G. (2009) SchistoDB: a Schistosoma mansoni genome resource. Nucleic Acids Res., 37, D579-D582.
31. Deng, J., Deng, L., Su, S., Zhang, M., Lin, X., Wei, L., Minai, A.A., Hassett, D.J. et al. (2011) Investigating the predictability of essential genes across distantly related organisms using an integrative approach.Nucleic Acids Res., 39, 795-807.
32. McCarter, J.P. (2004) Genomic filtering: an approach to discovering novel antiparasitics. Trends Parasitol., 20, 462-468.
33. Koonin, E.V. (2005) Orthologs, paralogs, and evolutionary genomics. Annu. Rev. Genet., 39, 309-338.
34. Wang, C.C. (1997) Validating targets for antiparasite chemotherapy. Parasitology, 114 (Suppl.), S31-S44.
35. Hardy, L.W. and Peet, N.P. (2004) The multiple orthogonal tools approach to define molecular causation in the validation of druggable targets. Drug Discov. Today, 9, 117-126.
36. Carter, N.S. and Fairlamb, A.H. (1993) Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature, 361, 173-176.
37. Maus, C.E., Plikaytis, B.B., and Shinnick, T.M. (2005) Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrob. Agents Chemother., 49, 3192-3197.
38. Behm, C.A., Bendig, M.M., McCarter, J.P., and Sluder, A.E. (2005) RNAi-based discovery and validation of new drug targets in filarial nematodes. Trends Parasitol., 21, 97-100.
39. Viney, M.E. (2006) The biology and genomics of Strongyloides. Med. Microbiol. Immunol., 195, 49-54.
40. Doyle, M.A.,Gasser, R.B.,Woodcroft, B.J., Hall, R.S., and Ralph, S.A. (2010) Drug target prediction and prioritization: using orthology to predict essentiality in parasite genomes. BMC Genomics, 11, 222.
41. Batada, N.N., Reguly, T., Breitkreutz, A., Boucher, L., Breitkreutz, B., Hurst, L.D., and Tyers, M. (2006) Stratus not altocumulus: a new view of the yeast protein interaction network. PLoS Biol., 4, e317.
42. Jeong, H., Mason, S.P., Barabási, A.L., and Oltvai, Z.N. (2001) Lethality and centrality in protein networks. Nature, 411, 41-42.
43. Lee, I., Lehner, B., Crombie, C.,Wong,W., Fraser, A.G., and Marcotte, E.M. (2008) A single gene network accurately predicts phenotypic effects of gene perturbation in Caenorhabditis elegans. Nat. Genet., 40, 181-188.
44. Wylie, T.,Martin, J., Abubucker, S., Yin, Y., Messina, D.,Wang, Z., McCarter, J.P., and Mitreva, M. (2008) NemaPath: online exploration of KEGG-based metabolic pathways for nematodes. BMC Genomics, 9, 525.
45. Crowther, G.J., Shanmugam, D., Carmona, S.J., Doyle, M.A., Hertz-Fowler, C., Berriman, M., Nwaka, S., Ralph, S.A. et al. (2010) Identification of attractive drug targets in neglected-disease pathogens using an in silico approach. PLoS Negl. Trop. Dis., 4, e804.
46. Parkinson, J., Whitton, C., Schmid, R., Thomson, M., and Blaxter, M. (2004) NEMBASE: a resource for parasitic nematode ESTs. Nucleic Acids Res., 32, D427-D430.
47. Geary, T.G., Klein, R.D., Vanover, L., Bowman, J.W., and Thompson, D.P. (1992) The nervous systems of helminths as targets for drugs. J. Parasitol., 78, 215-230.
48. Chikina, M.D., Huttenhower, C., Murphy, C.T., and Troyanskaya, O.G. (2009) Global prediction of tissuespecific gene expression and contextdependent gene networks in Caenorhabditis elegans. PLoS Comput. Biol., 5, e1000417.
49. Jackson, A.L., Bartz, S.R., Schelter, J., Kobayashi, S.V., Burchard, J., Mao, M., Li, B., Cavet, G. et al. (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol., 21, 635-637.
50. Rose, P.W., Beran, B., Bi, C., Bluhm,W.F., Dimitropoulos, D., Goodsell, D.S., Prlic, A., Quesada, M. et al. (2011) The RCSB Protein Data Bank: redesigned web site and web services. Nucleic Acids Res., 39, D392-401.
51. Magariños, M.P., Carmona, S.J., Crowther, G.J., Ralph, S.A., Roos, D.S., Shanmugam, D., Van Voorhis, W.C., and Agüero, F. (2012) TDR Targets: a chemogenomics resource for neglected diseases. Nucleic Acids Res., 40, D1118-D1127.